Intracellular Bacteria: Catch me if you can
Infectious diseases are one of the main causes of death worldwide. Several of the most deadly bacterial pathogens, such as Salmonella enterica and Listeria monocytogenes, cause disease by multiplying inside human cells. The human body is constantly patrolled by immune cells, and contains lots of antibodies and other molecules that can target and kill microbes, but the environment inside host cells provides a safe haven where certain pathogens can avoid detection by the immune system. However, each host cell can contain only a limited number of these intracellular bacteria so, after several rounds of replication, they need to leave the infected cell and invade other cells in order to continue multiplying. Until recently the details of how intracellular bacteria can spread between cells without being detected and killed by the immune system were poorly understood.
Now, in eLife, Tom Kawula of the University of North Carolina and colleagues – including Shaun Steele as first author – report how experiments on Francisella tularensis, a bacterium that causes a disease known as tularemia, have revealed more details about this process (Steele et al., 2016). F. tularensis replicates in the cytosol of immune cells called macrophages and hundreds of them can live inside a single host cell (Celli and Zahrt, 2013). Previous studies have revealed that some intracellular bacteria, including L. monocytogenes, grow an actin tail in order to move between epithelial cells (Figure 1; Welch and Way, 2013). However, F. tularensis is unable to form an actin tail so it must rely on a different mechanism to spread around the body.

Intracellular bacteria can spread between host cells in different ways.
The environment surrounding the host cells is full of immune cells as well as proteins from the complement system (orange), defensins (purple) and antibodies (grey). Top: After several rounds of replication in host cells, certain intracellular bacteria (green), including L. monocytogenes, have the ability to make an actin tail that can propel them from an infected cell (shown in blue) towards a neighbouring epithelial cell (yellow). This causes part of the infected cell membrane to bulge into the neighbouring cell, which eventually results in the bacteria being taken into the neighbouring cell surrounded by two layers of membrane (one from each cell). Bacteria then break down the two membranes to be released into the cytosol. Bottom: Steele et al. found that F. tularensis and S. enterica can transfer between macrophages through a trogocytosis-associated process. Uninfected macrophages (yellow) acquire bacteria from infected macrophages (blue) following temporary contact between the cells. Afterwards, the cells separate and the bacteria start to replicate in the acceptor cell (blue-yellow; the original blue donor cell is not shown). This bacterial cell-to-cell transfer is also associated with the exchange of membrane, membrane proteins and cytosol.
Using video-microscopy, Steele et al. observed that uninfected macrophages acquire F. tularensis from infected macrophages following a brief cell-to-cell contact. This process does not kill the cells involved, or expose the bacteria to immune responses outside the cells. Moreover, the exchange of materials between two macrophages is not restricted to pathogens that live in the cytosol: Steele et al. demonstrate that macrophages can also exchange latex beads and plasma membrane. The researchers also demonstrate that S. enterica – which lives inside host cell compartments called vacuoles – can be transferred between macrophages in the same way. The active exchange of plasma membrane and membrane proteins was first observed in other immune cells called lymphocytes over a decade ago and is called trogocytosis (from the Greek Trogo=to nibble; Joly and Hudrisier, 2003).
The process discovered by Steele et al. joins a list of strategies that bacteria, viruses and other intracellular pathogens are known to use to spread in their host (reviewed in Sattenau, 2008). These other strategies include the fusion of infected cells with surrounding cells, the use of membrane structures that bridge the gaps between cells (Sherer and Mothes, 2008), and the exploitation of the mechanism by which macrophages recognize and engulf dying cells (Czuczman et al., 2014).
Trogocytosis is a normal process that mainly involves macrophages and other immune cells, such as monocytes. It happens more often upon infection, specifically between infected macrophages and their donor cells. This observation suggests that trogocytosis is regulated by individual cells upon infection. A remarkable feature of this process is that membrane proteins that are exchanged between cells – such as the Major Histocompatibility Complex (MHC) molecules, which help to activate immune responses – continue to work properly in their new cell. Therefore, trogocytosis may serve as a surveillance mechanism for the immune system.
The molecular mechanisms underlying trogocytosis and the associated transfer of intracellular bacteria remain to be deciphered. This task will be particularly challenging since it is not currently possible to block trogocytosis with genetic techniques or specific inhibitor drugs. Further experiments are needed to visualize the cellular structures involved in the process, and to understand how the transfer of bacteria is regulated. It will also be important to understand the impact of trogocytosis-associated transfer on other processes, notably innate immune signaling (Ablasser et al., 2013), the presentation of antigens (including the possible transfer of the MHC between cells; Campana et al., 2015), and the spread of the bacteria within the host.
References
-
Cross-dressing: an alternative mechanism for antigen presentationImmunology Letters 168:349–354.https://doi.org/10.1016/j.imlet.2015.11.002
-
Mechanisms of Francisella tularensis intracellular pathogenesisCold Spring Harbor Perspectives in Medicine 3:a010314.https://doi.org/10.1101/cshperspect.a010314
-
What is trogocytosis and what is its purpose?Nature Immunology 4:815.https://doi.org/10.1038/ni0903-815
-
Avoiding the void: cell-to-cell spread of human virusesNature Reviews Microbiology 6:815–826.https://doi.org/10.1038/nrmicro1972
-
Cytonemes and tunneling nanotubules in cell–cell communication and viral pathogenesisTrends in Cell Biology 18:414–420.https://doi.org/10.1016/j.tcb.2008.07.003
-
Arp2/3-mediated actin-based motility: a tail of pathogen abuseCell Host & Microbe 14:242–255.https://doi.org/10.1016/j.chom.2013.08.011
Article and author information
Author details
Publication history
Copyright
© 2016, Bourdonnay et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 9,692
- views
-
- 496
- downloads
-
- 11
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Immunology and Inflammation
Macrophages are crucial in the body’s inflammatory response, with tightly regulated functions for optimal immune system performance. Our study reveals that the RAS–p110α signalling pathway, known for its involvement in various biological processes and tumourigenesis, regulates two vital aspects of the inflammatory response in macrophages: the initial monocyte movement and later-stage lysosomal function. Disrupting this pathway, either in a mouse model or through drug intervention, hampers the inflammatory response, leading to delayed resolution and the development of more severe acute inflammatory reactions in live models. This discovery uncovers a previously unknown role of the p110α isoform in immune regulation within macrophages, offering insight into the complex mechanisms governing their function during inflammation and opening new avenues for modulating inflammatory responses.
-
- Immunology and Inflammation
- Microbiology and Infectious Disease
Pseudomonas aeruginosa (PA) is an opportunistic, frequently multidrug-resistant pathogen that can cause severe infections in hospitalized patients. Antibodies against the PA virulence factor, PcrV, protect from death and disease in a variety of animal models. However, clinical trials of PcrV-binding antibody-based products have thus far failed to demonstrate benefit. Prior candidates were derivations of antibodies identified using protein-immunized animal systems and required extensive engineering to optimize binding and/or reduce immunogenicity. Of note, PA infections are common in people with cystic fibrosis (pwCF), who are generally believed to mount normal adaptive immune responses. Here, we utilized a tetramer reagent to detect and isolate PcrV-specific B cells in pwCF and, via single-cell sorting and paired-chain sequencing, identified the B cell receptor (BCR) variable region sequences that confer PcrV-specificity. We derived multiple high affinity anti-PcrV monoclonal antibodies (mAbs) from PcrV-specific B cells across three donors, including mAbs that exhibit potent anti-PA activity in a murine pneumonia model. This robust strategy for mAb discovery expands what is known about PA-specific B cells in pwCF and yields novel mAbs with potential for future clinical use.